PND155 - REDUCED RELAPSE RATES AND IMPROVED QUALITY OF LIFE FOR RELAPSING-REMITTING MULTIPLE SCLEROSIS (RRMS) PATIENTS TREATED WITH NATALIZUMAB VS INJECTABLE THERAPIES
Oct 1, 2018, 00:00
10.1016/j.jval.2018.09.2903
https://www.valueinhealthjournal.com/article/S1098-3015(18)36278-8/fulltext
Title :
PND155 - REDUCED RELAPSE RATES AND IMPROVED QUALITY OF LIFE FOR RELAPSING-REMITTING MULTIPLE SCLEROSIS (RRMS) PATIENTS TREATED WITH NATALIZUMAB VS INJECTABLE THERAPIES
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)36278-8&doi=10.1016/j.jval.2018.09.2903
First page :
Section Title :
Open access? :
No
Section Order :
1465